Oveis Jamialahmadi、Shahir Mowlaei、Kyla Z Gelev、Rosellina M Mancina、Valentina Flagiello、Julia Kozlitina、Päivi Pajukanta、Luca Valenti、Stefano Romeo
作者机构
Centre for Reproduction, Metabolism and Molecular Medicine (CeRM), Department of Medicine, Karolinska Institute, Huddinge, Sweden. oveis.jamialahmadi@ki.se.
Centre for Reproduction, Metabolism and Molecular Medicine (CeRM), Department of Medicine, Karolinska Institute, Huddinge, Sweden.
Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Department of Life Science, Health, and Health Professions, Link Campus University, Rome, Italy.
Operative Research Unit of Clinical Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
The Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Bioinformatics Interdepartmental Program, UCLA, Los Angeles, CA, USA.
Institute for Precision Health, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Precision Medicine and Biological Resource Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milan, Italy.
Centre for Reproduction, Metabolism and Molecular Medicine (CeRM), Department of Medicine, Karolinska Institute, Huddinge, Sweden. stefano.romeo@ki.se.
Department of Endocrinology, Karolinska University Hospital, Huddinge, Sweden. stefano.romeo@ki.se.
Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy. stefano.romeo@ki.se.
Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. stefano.romeo@ki.se.
Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden. stefano.romeo@ki.se.
技术路线
MRI衍生肝脏甘油三酯含量数据(71,488名欧洲 ancestry UK Biobank参与者)→全基因组关联研究荟萃分析→识别60个独立位点(31个新位点)并估计SNP遗传力为25%→整合精细定位与基因优先级分析提名48个位点的候选效应基因→在临床诊断的代谢功能障碍相关脂肪性肝病荟萃分析(42,163例病例和1,646,254例对照)中验证31个新位点中的14个→多基因风险评分与肝硬化(OR 2.71)和肝细胞癌(OR 7.47)风险关联分析→与多基因风险评分相关的血浆蛋白通路富集分析(代谢重塑和炎症通路,肝脏富集蛋白特征增加、内脏脂肪特征减少)
Comparative screening identifies gga-miR-204 as a nutrient-responsive miRNA that targets MAP1LC3B and promotes infectious bursal disease virus replication in HD11 cells.
College of Animal Science and Technology, Yangzhou University, 48 East Wenhui Road, Yangzhou, Jiangsu, 225009, China. Electronic address: mrrchen@yzu.edu.cn.
College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, China.
College of Animal Science and Technology, Yangzhou University, 48 East Wenhui Road, Yangzhou, Jiangsu, 225009, China.
Santosh S Atanur、Fengyuan Hu、Haiyi Lou、Xiaoyin Li、Xueqing Zoe Zou、Sean O'Dell、Sri V V Deevi、Paula Sawczuk、Karyn Megy、Zammy Fairhurst-Hunter、Amanda O'Neill、AstraZeneca Genomics Initiative、Lifeng Tian、Keren Carss、Jonathan Mitchell、Stewart MacArthur、Sebastian Wasilewski、Ryan S Dhindsa、Quanli Wang、Katherine R Smith、Oliver S Burren、Slavé Petrovski
作者机构
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Electronic address: santosh.atanur@astrazeneca.com.
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Shanghai, China.
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA.
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.
Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK; Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia. Electronic address: slav.petrovski@astrazeneca.com.
为什么值得关注
暂未整理